These findings may support the finding that patients with UGT1A1 *1/*6 or *1/*28 are at higher risk of nal-IRI-induced severe neutropenia than those with UGT1A1*1/*1. This evidence concerns the gene UGT1A1 and Decreased total neutrophil count.